This inventor holds 3 USPTO granted patents and 3 EPO patents. Top assignee: Cj Cheiljedang Corporation. Active years: 2017-2018.
Company Filing History:
Years Active: 2017-2018
Title: Bo Kyung Son: Innovator in Bacteriophage Research
Introduction
Bo Kyung Son is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of bacteriophage research, holding a total of 3 patents. His work focuses on developing novel solutions for preventing and treating infectious diseases.
Latest Patents
Bo Kyung Son's latest patents include innovative compositions involving bacteriophages. One of his notable inventions is a novel bacteriophage, designated as ΦCJ26 (KCCM11464P), which is used in a composition aimed at preventing and treating infectious diseases. Another significant patent features a bacteriophage, ΦCJ22 (KCCM11364P), which is incorporated into an antibacterial composition for use in animals, excluding humans. These inventions highlight his commitment to advancing medical science through innovative research.
Career Highlights
Bo Kyung Son is affiliated with CJ Cheiljedang Corporation, where he continues to push the boundaries of bacteriophage technology. His work has garnered attention for its potential applications in healthcare and disease management.
Collaborations
Throughout his career, Bo Kyung Son has collaborated with talented individuals such as Gi Duk Bae and Jae Won Kim. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Bo Kyung Son's contributions to bacteriophage research exemplify the impact of innovative thinking in addressing public health challenges. His patents and ongoing work at CJ Cheiljedang Corporation position him as a key figure in the field of infectious disease prevention and treatment.